Reistone Biopharma
一家源于China的处于临床阶段的生物技术公司,聚焦于研发自身免疫疾病领域的创新药,为China和全世界患者提供未满足的临床用药。
Yufeng Wang
Senior Director BDRemeGen
RemeGen is committed to the discovery, development and commercialization of innovative and differentiated biological drugs. We strive to continuously create value through our clinical studies to develop products that meet the unmet clinical needs. We aim to become a global leader in the bio-pharmaceutical industry
贵 黄
投资副总裁Rongsheng Investment
Rongsheng focuses on biotechnology companies and biomedical funds worldwide, especially innovative drugs and breakthrough therapies.
Mrs. SHA LIN
Investment managerSangel Capital
Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and US. The firm seeks to invest in innovative startups in sectors including biopharma, diagnostics, medical devices, and biotech.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Haipeng Cheng
Sanofi
Big Pharma
媛 李
clinicalAmy Sung
Sr launch excellence managernancy jiang
strategy&bd managerMiss Chara Wang
FBPShaanxi Kaisheng Capital Management Co.,Ltd
Armoured hold the Tianyi Group layout of science and technology investment capital investment platform. Armoured capital in order to create long-term value for the purpose, committed to accelerate the transformation of scientific and technological industry and fall to the ground, accelerate the development of innovative enterprise, and industry potential industry and change. So far, has invested Zephyrm Biotechnologies, Milky Way motivation, CSTshen, companies such as the future and will continue to pay attention to the capitalization of the business process and industry, seek the change from a single financial investment to the strategy of diversifying investment.

English (UK)
中文版
Responsive Web Design powered by